The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of avelumab with hypofractionated thoracic radiation therapy (HT-RT) in patients with metastatic soft-tissue sarcomas (mSTS).
 
Shane H Zaidi
Consulting or Advisory Role - GenesisCare
Research Funding - Merck KGaA (Inst)
 
Nicos Fotiadis
Honoraria - Amgen; Ethicon/Johnson & Johnson
Consulting or Advisory Role - Boston Scientific
Speakers' Bureau - Amgen
Research Funding - Ethicon/Johnson & Johnson (Inst)
 
Yolanda Augustin
No Relationships to Disclose
 
Andrea Napolitano
No Relationships to Disclose
 
Caitriona Goggin
No Relationships to Disclose
 
Bernice Asare
No Relationships to Disclose
 
Elizabeth Barquin
No Relationships to Disclose
 
Steven Edmunds
No Relationships to Disclose
 
Khin Thway
No Relationships to Disclose
 
Charlotte Benson
No Relationships to Disclose
 
Robin L Jones
Consulting or Advisory Role - Adaptimmune; Astex Pharmaceuticals; Athenex; Bayer; BluePrint Research Group; Boehringer Ingelheim; Clinigen Group; Daiichi Sankyo Pharmaceutical; Deciphera; Eisai; Epizyme; Immune Design; Immunicum; Karma Oncology; Lilly O.; Merck; Mundipharma; PharmaMar; SpringWorks Therapeutics; SynOX; TRACON Pharma; UpToDate
Research Funding - GlaxoSmithKline; MSD (Inst)
 
Aisha B Miah
No Relationships to Disclose